قالب وردپرس درنا توس
Home / Business / Surescripts makes it difficult for Amazon PillPack to access patient data

Surescripts makes it difficult for Amazon PillPack to access patient data



A pharmacist counts prescription drugs at the CenterTown Pharmacy in Ottawa, Ontario, Canada, June 12, 2019.

Chris Wattie | REUTERS

Surescripts, a company that manages electronic prescriptions, said this week.

Surescripts, a company that manages electronic prescriptions, said this week it is ceasing its relationship with ReMy Health over a patient data dispute. That move has serious repercussions for Amazon-owned PillPack, which had a deal with ReMy.

Now, PillPack has not officially cleared it patient or their doctor.

Surescripts said it was being investigated for the purpose of investigating ReMy Health and found problems with the service , leading it to terminate its contract. It also stated that it was "Turning the matter over to the FBI for further investigation."

Surescripts reported that it was not clear evidence of a patient's privacy violation.

Surescripts has uncovered evidence that the fraud in connection with ReMy Health's requests for patient information, "said the company's CEO Tom Skelton, in an email to customers that shared with CNBC.

Skelton said the volume of activity was "very small, but it took the step to maintain the health." "integrity of its network."

Surescripts is owned by a group of potential PillPack competitors, including CVS and Express Scripts, and manages about 80% of all US prescriptions. In April, the Federal Trade Commission sued the company, alleging "illegal monopolization of e-prescription markets."

ReMy's CEO told CNBC the allegations are unfounded and that it has been acted in compliance with its agreement with Surescripts.

"We have never provided any data from the Surescripts Network for Pharmaceutical Companies for Marketing Purposes," said ReMy CEO Aaron Crittenden, adding that the company's mission to make it more affordable "should not be a threatening proposition to anyone."

"PillPack is hopeful we can work directly with Surescripts, the only commercial clearinghouse."

PillPack said in a statement that Surescripts' actions will have an impact on its business for comprehensive medication history in the US, "said spokesperson Jacquelyn Miller. Miller added: "This is a Surescripts executive acknowledged in an interview with Politico Pro that patient's memory is sometimes faulty," and she said that PIllPack agreed with that sentiment.

"[We] hope that Surescripts wants patients and

Follow @CNBC t ech on Twitter for the latest tech industry news.


Source link